Non-neonatal hypoglycemia (peds): Difference between revisions

m (Rossdonaldson1 moved page Hypoglycemia (peds) to Non-neonatal hypoglycemia (peds))
(Add peer-reviewed reference)
 
(4 intermediate revisions by 2 users not shown)
Line 1: Line 1:
''This page is for <u>non-neonatal pediatric</u> hypoglycemia. See [[hypoglycemia]] for adult patients or [[neonatal hypoglycemia]].''
==Background==
==Background==
===Etiology===
===Etiology===
*Inadequate oral intake
*Inadequate oral intake
*Excess insulin
*Excess insulin
**Newborns of diabetic mothers
**Newborns of [[DM|diabetic mothers]]
*Deficient hyperglycemic hormones (GH or adrenal hormone deficiency)
*Deficient hyperglycemic hormones (growth or [[CAH|adrenal hormone deficiency]])
*Fatty acid oxidation or carbohydrate metabolism disorders
*[[Inborn errors of metabolism]]: fatty acid oxidation or carbohydrate metabolism disorders
*Prematurity (inadequate glycogen stores)
*Prematurity (inadequate glycogen stores)
*Sepsis
*[[Sepsis (peds)|Sepsis]]
*Etoh exposure (children have low glycogen stores)
*[[ETOH]] exposure (children have low glycogen stores)


==Clinical Features==
==Clinical Features==
*Most common features: vomiting, altered mental status, poor feeding
*Most common features: <ref>Thornton PS, et al. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children. J Pediatr. 2015;167(2):238-245. PMID 25957977</ref>
**May also see lethargy, apnea, seizure
**[[nausea and vomiting (peds)|Vomiting]]
**[[altered mental status (peds)|Altered mental status]]
**[[failure to thrive (peds)|Poor feeding]]
**May also see lethargy, apnea, [[seizure (peds)|seizure]]


==Differential Diagnosis==
==Differential Diagnosis==
*Ingestions (e.g. ETOH)
====Systemic Illness====
*Metabolic disease^
*Critical Illness
*[[Sepsis (peds)|Sepsis]]
**[[Sepsis (peds)|Sepsis]]
*Organ Failure
**[[Hepatic failure]]
**[[Renal failure]]
*Endocrinopathy
**[[Adrenal insufficiency]], [[congenital adrenal hyperplasia]]
*[[Seizure (peds)|Seizure]]
*[[Inborn errors of metabolism]]
 
====Drugs====
*Anti-hyperglycemic
**[[Insulin]]
**Oral secretagogue
***[[Sulfonylurea toxicity]]
*Other
**[[EtOH]]
**[[B-blocker]]
**[[ACE inhibitor|ACEI]]
**[[Acetaminophen Overdose|Acetaminophen (OD)]]
 
====Malignancy====
*Insulinoma
*Non-islet cell
*Insulin/receptor autoantibodies
*High tumor burden
====Other====
*Artifactual
**Specimen collection
**Consumption
***[[Leukemia (peds)|Leukemia]]
***Erythrocytosis
***[[hemolytic anemia|Hemolytic disease]]
*Starvation
**[[Anorexia nervosa]]
 
====Precipitants of anti-hyperglycemic induced hypoglycemia====
*Decreased glucose
**Missed meal
**Consumption (exercise, illness)
*Increased drug
**Error (patient, provider)
**Intentional overdose
**Increased availability
***[[Hepatic failure]]
***[[Renal failure]]
***Drug interaction


==Evaluation==
==Evaluation==
Line 53: Line 102:
[[Category:Pediatrics]]
[[Category:Pediatrics]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:FEN]]

Latest revision as of 10:16, 22 March 2026

This page is for non-neonatal pediatric hypoglycemia. See hypoglycemia for adult patients or neonatal hypoglycemia.

Background

Etiology

Clinical Features

Differential Diagnosis

Systemic Illness

Drugs

Malignancy

  • Insulinoma
  • Non-islet cell
  • Insulin/receptor autoantibodies
  • High tumor burden

Other

Precipitants of anti-hyperglycemic induced hypoglycemia

  • Decreased glucose
    • Missed meal
    • Consumption (exercise, illness)
  • Increased drug

Evaluation

Work-Up

  • Blood glucose level
  • Urinalysis
    • If ketones: adrenal or GH deficiency, inborn errors of metabolism
    • If no ketones: Hyperinsulinemia, fatty acid oxidation defects

Diagnosis

  • Blood glucose <45 in symptomatic neonate
  • Blood glucose <35 in asymptomatic neonate

Management

See critical care quick reference for doses by weight

  • Glucose
    • Bolus D10W 2mL/kg; then infuse D10W at 0.06-0.08mL/kg/min
  • Glucagon
    • Used for persistent hypoglycemia despite glucose administration
    • Will not work with etoh exposure as glycogen stores are already low
    • 0.03mg/kg IM/IV

Pediatric Hypoglycemia Dextrose Chart

Category Age Glucose Treatment Initial IV Bolus Maintenance Dose
Neonatal <2mo <40 D10W 2.5-5 mL/kg 6 mL/kg/h
Pediatric 2mo-8yrs <60 D25W 2 mL/kg

D10W:

  • 6 mL/kg/h for first 10 kg
  • + 3 mL/kg/h for 11–20 kg
  • + 1.5 mL/kg/h for each additional kg >20 kg
Adult >8yrs <70 D50W 50mL (1 amp) OR 1 mL/kg
  • Consider diluting the D25W or D50W bolus, with NS 1-to-1, as those concentrations may be sclerosing to veins
  • Recheck 5 minutes after dose and repeat dose if low.
  • Consider glucagon IM/SQ if IV access is not readily available

Disposition

See Also

References

  1. Thornton PS, et al. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children. J Pediatr. 2015;167(2):238-245. PMID 25957977